Skip to main content

Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS)

Submitted by lsekela on December 14, 2018 - 09:47 AM

The US Biomedical Advanced Research and Development Authority (BARDA) conducted a randomized, double-blinded Phase 2 clinical study with the oldest stockpiled influenza A(H5N1) antigen, stored over the previous 10–12 years administered with or without MF59® adjuvant, stored over the previous 2–7 years at the time of vaccination.

Content Source:

Vaccine

Content Author:

Christine M.Oshanskya, James Zhoua, Yonghong Gaoa

Tags: